{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:17:11Z","timestamp":1790813831194,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ymgme.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T14:03:13Z","timestamp":1557410593000},"page":"282-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between hepatitis C virus and porphyria cutanea tarda"],"prefix":"10.1016","volume":"128","author":[{"given":"Jordi","family":"To-Figueras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ymgme.2019.05.003_bb0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM198204013061309","article-title":"The enzymatic defect in porphyria cutanea tarda","volume":"306","author":"Kushner","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2019.05.003_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02110035","article-title":"Uroporphyrinogen decarboxylase","volume":"27","author":"Elder","year":"1995","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01483617","article-title":"Pathogenesis and therapy of porphyria cutanea tarda (chronic hepatic porphyria)","volume":"38","author":"Ippen","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0020","series-title":"Treatment of porphyria cutanea tarda by phlebotomy","first-page":"253","volume":"14","author":"Ippen","year":"1977"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1007142","article-title":"Porphyria cutanea tarda","volume":"18","author":"Elder","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0030","series-title":"The Porphyrin Handbook: Medical Aspects of Porphyria","first-page":"169","article-title":"Porphyria Cutanea Tarda","volume":"14","author":"Elder","year":"2003"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0035","series-title":"Handbook of Porphyrin Science","article-title":"Porphyria cutanea tarda","author":"Singal","year":"2014"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2019.01.004","article-title":"Porphyria cutanea tarda: Recent update","author":"Singal","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2019.05.003_bb0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI108136","article-title":"The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase","volume":"56","author":"Kushner","year":"1975","journal-title":"J. Clin. Invest."},{"issue":"29","key":"10.1016\/j.ymgme.2019.05.003_bb0050","first-page":"243","article-title":"Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect","volume":"14","author":"Felsher","year":"1977","journal-title":"Semin. Hematol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.05.003_bb0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/abbi.1997.0306","article-title":"Release of iron from ferritin storage by redox cycling of stilbene and steroid estrogen metabolites: a mechanism of induction of free radical damage by estrogen","volume":"346","author":"Wyllie","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"issue":"1 Suppl","key":"10.1016\/j.ymgme.2019.05.003_bb0060","first-page":"S2","article-title":"Hepcidin is down-regulated in alcohol loading","volume":"31","author":"Ohtake","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.ymgme.2019.05.003_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2019.05.003_bb0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","article-title":"Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda","volume":"95","author":"Bulaj","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ymgme.2019.05.003_bb0075","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1523-1747.2000.00148.x","article-title":"Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda","volume":"115","author":"Brady","year":"2000","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.ymgme.2019.05.003_bb0080","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/tx900298k","article-title":"GH. Complex gene-chemical interactions: hepatic uroporphyria as a paradigm","volume":"23","author":"Smith","year":"2010","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.ymgme.2019.05.003_bb0085","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","article-title":"Hepatitis C, porphyria cutanea tarda, and liver iron: an update","volume":"32","author":"Caballes","year":"2012","journal-title":"Liver. Int."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-291X(82)91573-X","article-title":"Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene","volume":"109","author":"Elder","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.ymgme.2019.05.003_bb0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/00498259009046902","article-title":"Oxidative injury mediated by the hepatic cytochrome P-450 system in conjunction with cellular iron. Effects on the pathway of haem biosynthesis","volume":"20","author":"Smith","year":"1990","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.ymgme.2019.05.003_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/bj3300149","article-title":"Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(\u2212\/\u2212) null mutant mice","volume":"330","author":"Sinclair","year":"1998","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ymgme.2019.05.003_bb0110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/bj2140909","article-title":"Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice","volume":"214","author":"Smith","year":"1983","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ymgme.2019.05.003_bb0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/tx700176r","article-title":"Essential role of the AH receptor in the dysfunction of heme metabolism induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"21","author":"Davies","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0120","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","article-title":"Hepatitis C virus andporphyria cutanea tarda: evidence of a strong association","volume":"16","author":"Fargion","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0125","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0140-6736(93)90562-U","article-title":"Is hepatitis C virus infection a trigger of porphyria cutanea tarda?","volume":"341","author":"Herrero","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MD.0b013e3181d50928","article-title":"Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients","volume":"89","author":"Mu\u00f1oz-Santos","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/00015550510033688","article-title":"Porphyria cutanea tarda in a Swedish population: risk factors and complications","volume":"85","author":"Rossmann-Ringdahl","year":"2005","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1157\/13090276","article-title":"Hepatitis C in Spain","volume":"127","author":"Bruguera","year":"2006","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/phpp.12222","article-title":"Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital","volume":"32","author":"Aguilera","year":"2016","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"3","key":"10.1016\/j.ymgme.2019.05.003_bb0150","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520310000672a","article-title":"Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C","volume":"38","author":"Fern\u00e1ndez","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.05.003_bb0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/clpt.2013.206","article-title":"Novel therapeutic approaches for hepatitis C","volume":"95","author":"Au","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0160","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/bjd.13376","article-title":"Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda","volume":"171","author":"Aguilera","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.ymgme.2019.05.003_bb0165","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/bjd.15502","article-title":"P. Aguilera Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda","volume":"177","author":"Combalia","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0170","first-page":"251","article-title":"Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda","volume":"33","author":"To-Figueras","year":"2003","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"6","key":"10.1016\/j.ymgme.2019.05.003_bb0175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.amjms.2017.03.007","article-title":"Hepatitis C treatment in patients with Porphyria Cutanea Tarda","volume":"353","author":"Singal","year":"2017","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.ymgme.2019.05.003_bb0180","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/jdv.14186","article-title":"Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era","volume":"31","author":"Wiznia","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10","key":"10.1016\/j.ymgme.2019.05.003_bb0185","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/jac\/dkx222","article-title":"Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy","volume":"72","author":"Bruzzone","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0190","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamadermatol.2016.3036","article-title":"Resolution of porphyria cutanea tarda in patients with hepatitis C following ledipasvir-sofosbuvir combination therapy","volume":"152","author":"Tong","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ymgme.2019.05.003_bb0195","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1111\/jdv.13936","article-title":"Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?","volume":"31","author":"Hatch","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.ymgme.2019.05.003_bb0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12328-017-0772-x","article-title":"Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir\/sofosbuvir for hepatitis C","volume":"10","author":"Takata","year":"2017","journal-title":"Clin. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ymgme.2019.05.003_bb0205","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/1346-8138.14716","article-title":"Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct-acting antivirals: a case report","volume":"46","author":"Nihei","year":"2019","journal-title":"J. Dermatol."},{"issue":"10","key":"10.1016\/j.ymgme.2019.05.003_bb0210","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/jac\/dkx222","article-title":"Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy","volume":"72","author":"Bruzzone","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.ymgme.2019.05.003_bb0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0676.1990.tb00456.x","article-title":"Are there diagnostic histologic features of porphyria cutanea tarda in liver biopsy specimens?","volume":"10","author":"Campo","year":"1990","journal-title":"Liver"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0220","series-title":"Estudio del metabolismo del hierro en la porfiria cutanea tarda","author":"Bassas","year":"1990"},{"issue":"2","key":"10.1016\/j.ymgme.2019.05.003_bb0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1572-0241.2005.41112.x","article-title":"Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin","volume":"100","author":"Rulyak","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ymgme.2019.05.003_bb0230","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jhep.2004.02.030","article-title":"Hepatic iron concentration does not predict response to standard and pegylated-IFN\/ribavirin therapy in patients with chronic hepatitis C","volume":"40","author":"Hofer","year":"2004","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.05.003_bb0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.gastro.2007.10.011","article-title":"Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription","volume":"134","author":"Nishina","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ymgme.2019.05.003_bb0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840060106","article-title":"Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis","volume":"6","author":"Bassett","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2019.05.003_bb0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"Nemeth","year":"2009","journal-title":"Acta Haematol."},{"issue":"5","key":"10.1016\/j.ymgme.2019.05.003_bb0250","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2009.06.027","article-title":"Reduced serum hepcidin levels in patients with chronic hepatitis C","volume":"51","author":"Girelli","year":"2009","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ymgme.2019.05.003_bb0255","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1111\/j.1468-3083.2012.04511.x","article-title":"Increased serum hepcidin levels in patients with porphyria cutanea tarda","volume":"27","author":"Darwich","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"Suppl. 4","key":"10.1016\/j.ymgme.2019.05.003_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jgh.12243","article-title":"Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis","volume":"28","author":"Hino","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.ymgme.2019.05.003_bb0265","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1872-034X.2009.00497.x","article-title":"Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C","volume":"39","author":"Sugimoto","year":"2009","journal-title":"Hepatol. Res."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218305808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218305808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:24:36Z","timestamp":1761089076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218305808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1096719218305808"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.05.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between hepatitis C virus and porphyria cutanea tarda","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}